Patents by Inventor Paul Richard Sebahar

Paul Richard Sebahar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPV4 RECEPTOR LIGANDS
    Publication number: 20230026696
    Abstract: Described are receptor ligands of transient receptor potential cation channel subfamily V member 4 (TRPV4), pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for treating ocular disorders.
    Type: Application
    Filed: November 20, 2020
    Publication date: January 26, 2023
    Inventors: Paul Richard Sebahar, Ryan Looper, David Krizaj, Christopher A. Reilly, Seth Wilson Grant
  • Chemical compounds
    Patent number: 8304419
    Abstract: The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
    Type: Grant
    Filed: June 5, 2008
    Date of Patent: November 6, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Pek Yoke Chong, Andrew James Peat, Paul Richard Sebahar, Michael Youngman, Huichang Zhang
  • CHEMICAL COMPOUNDS
    Publication number: 20100216746
    Abstract: The present invention relates to compounds that are a non-nucleoside reverse transcriptase inhibitors, and to processes for the preparation and use of the same. Specifically, the present invention includes methods of using such compounds in the treatment of human immunodeficiency virus infection.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 26, 2010
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: PEK Yoke Chong, Andrew James Peat, Paul Richard Sebahar, Michael Youngman, Huichang Zhang
  • Chemical compounds
    Patent number: 7622494
    Abstract: The present invention relates to compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: November 24, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, John G Catalano, Kristjan S Gudmundsson, Leah D'Aurora Richardson, Paul Richard Sebahar
  • Tetrahydrocarbazole derivatives and their pharmaceutical use
    Patent number: 7351733
    Abstract: The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: April 1, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Sharon Davis Boggs, Kristjan S Gudmundsson, Leah D'Aurora Richardson, Paul Richard Sebahar